Université Clermont Auvergne

Universite De La Rochelle

Cnrs

Valbiotis

Université Blaise Pascal Clermont Ii

La Rochelle Université

Thierry Maugard

Pascal Sirvent

Sebastien Peltier

Vivien Chavanelle

Sébastien Peltier

Stephanie Bordenave-Juchereau

Jean-Marie Piot

Florian Le Joubioux

Yesmine Ben-Henda

Stéphanie Bordenave-Juchereau

The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(&#x3b2;-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.

Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals

A composition comprising at least: a single extract obtained from a mixture of at least two plants selected fromand. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.

Compositions and methods for controlling carbohydrate and fat metabolism

A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to &#x3c;5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.

Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase

A composition comprising at least a mixture of molecules obtained at least from:, andand wherein the mixture of molecules also comprises piperine. The composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.

This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of, an extract of, an extract of, an extract of, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.

Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism

Growing community of inventors

La Jarne, France

Thierry Maugard